The role of placebo response in the efficacy outcome assessment in viloxazine extended-release pivotal trials in paediatric subjects with attention-deficit/hyperactivity disorder.
作者:
主题词
注意力缺陷障碍伴多动(Attention Deficit Disorder with Hyperactivity);中枢神经系统刺激剂(Central Nervous System Stimulants);儿童(Child);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);迟效制剂(Delayed-Action Preparations);剂量效应关系, 药物(Dose-Response Relationship, Drug);人类(Humans);安慰治疗效应(Placebo Effect);治疗结果(Treatment Outcome);维洛沙秦(Viloxazine)
DOI
10.1111/bcp.15412
PMID
35588245
发布时间
2022-12-31
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文